baber/WOPTO huggingface dataset:
Patent FI-946101-A0 (FI)
Inventor: SOHLSTROEM LASSE
IPC: E04C2/08
Filed: 1994-12-27
Abstract: The present invention relates to a shield wall structure of a magnetic-shielded room and a method for producing a magnetic-shielded room. The shield wall structure consists of at least one shield structure layer when each shield structure comprises a first aluminium sheet layer (11), a two-ply layer composed of  mu  metal sheets (12,13), and a second layer (14) composed of aluminium sheets. In the aluminium sheet (11) constituting the first layer, holes (15) have been made at a hole spacing equivalent to the width of the  mu metal sheets (12,13). Support members (16) have been disposed in the holes (15). Supported to the support members (16), the first layer of mu  metal sheets (12) has been suspended, and on top of these, a second layer of  mu  metal sheets (13) in another direction. On top of the two-ply  mu  metal sheet structure (12,13), base sheets (14) of aluminium have been positioned in the support members (16). Tightening members (18) have been positioned in the support members (16) for compressing the entire wall structure (11,12;13,14) into a compact package. <IMAGE>
Patent FI-950762-A0 (FI)
Inventor: PHILLIP GUENTHER
IPC: C21D11/00
Filed: 1995-02-20
Abstract: PCT No. PCT/EP93/02222 Sec. 371 Date Apr. 5, 1995 Sec. 102(e) Date Apr. 5, 1995 PCT Filed Aug. 19, 1993 PCT Pub. No. WO94/04708 PCT Pub. Date Mar. 3, 1994A process and device are disclosed for regulating the annealing power in at least one annealing section of a continuous annealing and processing line for continuously cast metal products. The speed of the cast products (D) passing through the continuous annealing device is detected, as well as the voltage currently applied to the annealing section, which is converted into an effective value (Uc) by means of a control device (50). The voltage supplied to the annealing section is modified by a control signal derived from the determined effective value of the voltage, in order to achieve a predetermined annealing power value dependent on the measured speed. At least the current flowing in one annealing section is also detected and converted into an effective value. The annealing power actually supplied to the annealing section is calculated from said effective values. The voltage value is modified by a control device until a predetermined value of the annealing power is reached.
Patent FI-951901-A0 (FI)
Inventor: KWAN HENRY K
IPC: A61K9/24
Filed: 1995-04-21
Abstract: A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.
Patent FI-952534-A0 (FI)
Inventor: KESKITALO ILKKA
IPC: H04B1/04
Filed: 1995-05-24
Abstract: PCT No. PCT/FI96/00291 Sec. 371 Date Jan. 24, 1997 Sec. 102(e) Date Jan. 24, 1997 PCT Filed May 23, 1996 PCT Pub. No. WO96/37969 PCT Pub. Date Nov. 28, 1996In a cellular radio system having in each of a plurality of cells at least one base station communicating with mobile stations located within its area, the base stations each transmit a pilot signal to the mobile stations. At least one of the base stations, transmits to the mobile stations by transmitting a pilot signal by using a rather narrow changing antenna beam. The angle of the greatest gain of the antenna beam is controlled in such a way that the antenna beam sweeps the cell area. The mobile stations can use the pilot signal in the identification of a base station, and as an indicator of a need for handover, without the continuous reception of the pilot signal in the subscriber equipment, and without a need to transmit the pilot signal with a higher transmission power than the other signals.
Patent FI-954599-A0 (FI)
Inventor: MCSHANE JAMES E
IPC: A61Q19/04
Filed: 1995-09-28
Abstract: PCT No. PCT/US94/03258 Sec. 371 Date Nov. 13, 1995 Sec. 102(e) Date Nov. 13, 1995 PCT Filed Mar. 30, 1994 PCT Pub. No. WO94/22419 PCT Pub. Date Oct. 13, 1994Apparatus for simulating skin tanning comprises a receptacle containing a fluid comprising dihydroxyacetone, a receptacle containing a fluid comprising an amino acid, and dispensing means for simultaneously or sequentially providing desired amounts of dihydroxyacetone and amino acid.
Patent FI-963865-A0 (FI)
Inventor: SUGIURA MASAAKI
IPC: A01N47/02
Filed: 1996-09-27
Abstract: Bait for controlling harmful parasites, partic. insects, comprising an active 1-arylpyrazole deriv. of formula (I), is based on a substance which forms a gel upon hydration. R1 = CN, methyl or halo; R2 = S(O)nR3, 4,5-dicyanoimidazol-2-yl or haloalkyl; R3 = alkyl or haloalkyl; R4 = H, halo, NR5R6, S(O)mR7, C(O)R7, C(O)OR7, alkyl, haloalkyl OR8 or N=C(R9)(R10); R5, R6 = H, alkyl, haloalkyl, C(O)alkyl, alkoxycarbonyl or S(O)rCF3; or R5+R6 = alkylene (opt. interrupted by one or more heteroatoms e.g. O or S); R7 = alkyl or haloalkyl; R8 = H, alkyl or haloalkyl; R9 = H or alkyl; R10 = phenyl or heteroaryl (opt. substd. by one or more halo or by one -OH, -O-alkyl, -S-alkyl, cyano or alkyl); R11, R12 = H, halo, CN or NO2; R13 = halo, haloalkyl, haloalkoxy, S(O)qCF3 or SF5; X = trivalent N or C-R12, the three C valences forming part of an aromatic nucleus; m, n, q = 0-2; r is not defined; provided that if R1 = Me, then either R3 = haloalkyl, R4 = NH2, R11 = Cl, R 13 = CF3 and X = N; or R2 = 4,5-dicyanoimidazol-2-yl, R4 = Cl, R11 = Cl, R13 = CF3 and X = =C-Cl.
Patent FI-964816-A0 (FI)
Inventor: STANGER BERND
IPC: C08F2/22
Filed: 1996-12-02
Abstract: PCT No. PCT/EP95/00607 Sec. 371 Date Feb. 28, 1997 Sec. 102(e) Date Feb. 28, 1997 PCT Filed Feb. 22, 1995 PCT Pub. No. WO95/33775 PCT Pub. Date Dec. 14, 1995Described is a method of producing an aqueous polymer dispersion, the method calling for further polymerization of the dispersion using a radical mechanism redox initiator system including as the reducing agent the addition compound obtained between a lower ketone and hydrogen sulphite.
Patent IL-57385-A0 (IL)
Title: Vitamin b-12 derivatives suitable for radiolabeling and method for their preparation
IPC: A61K31/70
Filed: 1979-05-23
Abstract: Radiolabeled vitamin B12 derivatives having the formula  <IMAGE> wherein R is hydrogen or alkyl of 1 to 3 carbon atoms; n is 0, 1, 2, 3 or 4; and the asterisk (*) indicates tagging with a radioisotope, are useful as tracers in radioassays.
Patent IL-62961-A0 (IL)
Title: Method of disinfecting water by treatment with ozone
IPC: C02F1/78
Filed: 1981-05-26
Abstract: Ozone is generated from an oxygen-rich gas [10] preferably containing at least 70% O2 and the generated gas stream [12] employed in a process such as the ozonation of drinking water. The off gas [20] from the water treatment is split into a major fraction [21] which is dried and recycled to the ozone generation. A minor purge fraction [22] of the off gas [20] is employed in stripping nitrogen and carbon dioxide from the influent water subjected to disinfection by the generated ozone-containing gas.
Patent IL-63063-A0 (IL)
Title: Unglycosylated interferon
IPC: C07K14/56
Filed: 1981-06-10
Abstract: Unglycosylated human fibroblast and leucocyte interferons are disclosed together with fused genes coding therefor.
Patent IL-69023-A0 (IL)
Title: An enzyme conjugated matrix for testing for presence of malignancies,test methods and apparatus utilising the same and method for the preparation thereof
IPC: C12N11/00
Filed: 1983-06-17
Abstract: An improved, more convenient, more sensitive test for detection of certain malignancies in human and animal subjects is disclosed. Sera from test subjects is mixed with labeled DNA in the presence of an enzyme-conjugated matrix. Sera from normal and cancerous subjects react differently with the matrix, permitting a diagnosis of the subject.
Patent IL-96136-A0 (IL)
Title: Method for purification of recombinant copper/zinc(cu-zn)superoxide dismutase from bacteria or eucaryotic cells
IPC: C12N9/02
Filed: 1990-10-26
Abstract: Disclosed is a method of increasing the yield of recovered solutions having an increased concentration of b isoform of an enzymatically-active polypeptide analog of Cu-Zn superoxide dismutase from a composition which comprises cells containing a, b and c isoforms of the polypeptide analog comprising treating the composition to separate soluble proteins from whole cells, cellular debris and insoluble proteins to obtain a solution containing such soluble proteins, including the a, b and c isoforms; treating the resulting solution with soluble proteins to produce three separate solutions, each of which has an increased concentration of one of either of the a, b or c isoform; recovering the separate solution with an increased concentration of the b isoform; combining the separate solution with an increased concentration of the a isoform with the separate solution with an increased concentration of the c isoform; treating the resulting combined solution to produce a solution with an increased concentration of the b isoform and recovering the then-resulting solution with an increased concentration of the b isoform.
Patent IL-109274-A0 (IL)
Title: Primary alkaline electrochemical cell
IPC: H01M4/06
Filed: 1994-04-11
Abstract: The present invention is an improved alkaline cell wherein the capacity of each of the anode and cathode is at least 0.48 and more preferably to at least 0.5 ampere-hour per cm3 of internal cell volume. This is achieved by employing zinc densities of at least 1.4 grams of zinc per cm3 of anode volume and MnO2 densities of at least 2.7 grams of MnO2 per cm3 of cathode volume.
Patent IL-110563-A0 (IL)
Title: Substituted kynurenines, a process for the preparation thereof and pharmaceutical compositions containing the same
IPC: A61K31/165
Filed: 1994-08-04
Abstract: The present invention relates to the use in the treatment of cognitive disorders associted with the aging processes of the brain and perinatal brain disorders of compounds which act as inhibitors of the enzyme kynurenine aminotransferase (KAT). The present invention also provides, as novel compounds, a selected class of KAT inhibitors which are the compounds of formula (IA), wherein R is halogen, C1-C6 alkyl, C5-C7 cycloalkyl, phenyl-C1-C4 alkyl, C1-C6 alkoxy, C6-C10 aryloxy, phenyl-C1-C4 alkoxy or trifluoromethyl, and R1 is hydroxy, C1-C6 alkoxy, amino, mono-C1-C6 alkylamino di-C1-C6 alkylamino, hydroxylamino, C1-C4 alkoxyamino or benzyloxyamino, with the provisos that: (i) when R1 is hydroxy and at the same time, R is halogen, then this halogen is not fluorine; and (ii) when R1 is hydroxy and, at the same time, R is C1-C6 alkyl, then this C1-C6 alkyl is not methyl, either as a single isomer or as a mixture of isomers, and the pharmaceutically acceptable salts thereof.
Patent IL-114274-A0 (IL)
Title: Process for the preparation of a trihydrate of (2r,3s)-3- tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate from 4-acetoxy 2a-benzoyloxy-5b, 20-epoxy-1, 7b, 10b-trihydroxy-9- oxo-tax-11-en- 13a-yl
IPC: A61K31/335
Filed: 1995-06-22
Abstract: PCT No. PCT/FR95/00910 Sec. 371 Date Apr. 25, 1997 Sec. 102(e) Date Apr. 25, 1997 PCT Filed Jul. 7, 1995 PCT Pub. No. WO96/01815 PCT Pub. Date Jan. 25, 1996Process for the preparation of 4-acetoxy-2 alpha -benzoyloxy-5 beta ,20-epoxy-1,7 beta , 10 beta -trihydroxy-9-oxo-tax-11-en-13 alpha -yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate, characterized in that the 4-acetoxy-2 alpha -benzoyloxy-5 beta ,20-epoxy-1,7 beta ,10 beta -trihydroxy-9-oxo-tax-11-en-13 alpha -yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate is crystallized from a mixture of water and an aliphatic alcohol containing 1 to 3 carbon atoms, and then the product obtained is dried under defined conditions of temperature, pressure and humidity.
Patent IL-114631-A0 (IL)
Title: Anti-epileptics
Inventor: MARESCAUX CHRISTIAN PROF
IPC: C07F9/655
Filed: 1995-07-17
Abstract: Compounds having GABAB-antagonistic properties, for example those of formula I    <IMAGE>  (I)  wherein one of the radicals R1, R2 and R3 is hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another is hydrogen or, in the case of R1 or R2, hydroxy or, in the case of R1, halogen or, in the case of R2 together with R2', oxo, and the remaining radical is hydrogen, R1' is hydrogen or halogen, R2' is hydrogen, hydroxy or, together with R2, is oxo, R4 and R5 are hydrogen or R4 is an araliphatic or heteroarylaliphatic radical and R5 is hydrogen or an aliphatic radical, and R is an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, araliphatic, heteroarylaliphatic or aromatic radical having at least 2 carbon atoms or, when R1 is hydrogen or hydroxy, R2 is an aromatic radical and R1', R2' and R3 are hydrogen, R is methyl, and their pharmaceutically acceptable salts, can be used as active ingredients in medicaments for the treatment of epilepsies of the "petit mal"  type. The invention relates also to novel compounds of formula I and processes for the preparation thereof.
Patent IL-117244-A0 (IL)
Title: Apparatus and method for producing an extrudate
IPC: B30B11/22
Filed: 1996-02-23
Abstract: PCT No. PCT/GB96/00339 Sec. 371 Date Jan. 30, 1998 Sec. 102(e) Date Jan. 30, 1998 PCT Filed Feb. 13, 1996 PCT Pub. No. WO96/26828 PCT Pub. Date Sep. 6, 1996An apparatus for producing an extrudate (e.g., water-dispersable extruded rod-shaped granules) from an extrudable powder-based material (e.g., a finely-divided water-insoluble powder) includes a hopper for the extrudable material having at least one extrusion aperture at its lower end, a rotatable extruder tool at or near the lower end of a first drive shaft for forcing the extrudable material through the aperture(s) and a rotatable feeder at or near a lower end of a second drive shaft for feeding the extrudable material to the extruder tool. The first drive shaft is rotatably mounted within the second drive shaft by axially displaced bearings, the second drive shaft being mounted within a fixed bearing housing by further axially displaced bearings. Drive motors are connected by respective drive trains to the upper ends of the first and second drive shafts, respectively.
Patent IL-121631-A0 (IL)
Title: Process for the preparation of fertilizers and sulfur compounds
IPC: B01D53/50
Filed: 1997-08-26
Abstract: A method for the combined production of (I) a fertilizer selected from a group consisting of ammonium nitrate, ammonium phosphates or a combination thereof through an indirect neutralization of ammonia with an acid selected form a group consisting of nitric acid, phosphoric acid and a combination thereof and of (II) a sulfur compound selected from a group consisting of elemental sulfur, SO2, sulfuric acid and sulfate salts, said method comprising (a) contacting a sulfur oxide containing gas with ammonia and an aqueous liquor, whereby a sulfur oxide containing product is formed and the resulting gas has a reduced SO2 content; (b) reacting a sulfur oxide containing product resulting from step (a) with a reagent selected from a group consisting of nitric acid, phosphoric acid, a mixture thereof and salts formed by the reaction of said acids to form said fertilizer and a sulfur compund, and (c) separating at least a portion said sulfur compound from said fertilizer.
Patent IL-128283-A0 (IL)
Title: Sewing apparatus
IPC: D05B81/00
Filed: 1999-01-28
Abstract: The invention provides a novel sewing machine for carrying out in an improved manner sewing operations carried out by conventional sewing machines as well as operations that conventional sewing machines cannot perform, such as bonding fabrics without the use of threads and creating ornamental patterns in fabrics. The novel sewing machine comprises one or more containers (15) for one or more radiation curable polymer precursors, one or more injector (15-20, 28) devices for injecting the precursor(s) at selected targets, one or more sources (16) of curing radiation, dosing means for determining the volume of the precursor charge injected at each injection, and means (21) for synchronically activating the injector device and the radiation source. The polymer precursor(s) are injected in the fluid state at the selected target(s) and are then cured by polymerization or cross-linking to acquire a solid state. The novel sewing machine can also include one or more components of prior art sewing machines for the purpose of carrying out any desired operation that said components can carry out.
Patent IL-131374-A0 (IL)
Title: Marking device for electronic presentation board
IPC: B43K29/00
Filed: 1998-02-26
Abstract: A transmitter device is disclosed for use with a conventional pen in which the ultrasound transmitter is a cylindrical element lying coaxial with the pen and adjacent to its tip, and a jointed eraser structure. Conventional triangulation techniques are used to track the position and motion of a writer or eraser. An encoding facility associated with the pen provides the ability to distinguish whether the pen is used for marking or an as erasing implement, as well as determining the nature or character of written line width or eraser swath. A data stream thus generated can be used in a variety of ways, such as for example, to feed information into the memory of a digital computer, and/or to feed information for transmission to remote stations.
Patent IL-133721-A0 (IL)
Title: Sheathed synthetic fiber rope
IPC: D07B1/02
Filed: 1999-12-24
Abstract: The cable, of twisted plastics strands, has anchor elements (13) twisted into the outermost twisted strand layers (11), bonded to the outer mantle (14).  The anchor elements (13) and/or the outer mantle (14) are of materials which can be welded or vulcanized. The anchor element is at least one anchor strand (13) in at least one outer strand layer (11) with carrier strands (9). Or it is an anchor fiber twisted with the carrier strands at the outermost twisted strand layer.  An Independent claim is included for a cable manufacturing process where the anchor element (13) is twisted in place so that, when the outer mantle (14) is fitted, a mol. bond is formed between them.  Preferred Features: The anchor strand (13) is heated to its melting temp. before the mantle (14) is extruded over the twisted cable so that it is welded to the anchor. The anchors (13) are treated chemically before the mantle shrouding is in place, for the mantle and anchors to be vulcanized together.
Patent IL-134306-A0 (IL)
Title: Plastics pallets and moulding apparatus for producing plastics pallets and other plastic articles
IPC: B29D99/00
Filed: 1998-08-25
Abstract: A pallet of moulded construction comprising a load-carrying surface supported by underlying support structure configured to permit the insertion of the tines of the fork-lift, the load-carrying surface being reinforced at its underside by a cellular reinforcing structure comprising cells the axes of which extend perpendiculary to the load-carrying surface.
Patent IL-137536-A0 (IL)
Title: Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
IPC: A61K31/44
Filed: 1998-08-10
Abstract: The invention concerns omeprazole microgranules each comprising an active layer containing the active principle, and an outer gastroprotecting layer containing a gastroprotecting agent, characterized in that the omeprazole is combined with at least a hydrophobic substance.
Patent IL-154852-A0 (IL)
Title: Eye gaze for contextual speech recognition
IPC: G10L15/26
Filed: 2001-09-13
Abstract: A method for discriminating between an instance of a voice command and an instance of speech dictation can include identifying a focus point in a user interface; defining a surrounding region about the focus point; identifying user interface objects in the surrounding region; further identifying among the identified user interface objects those user interface objects which are configured to accept speech dictated text and those user interface objects which are not configured to accept speech dictated text; computing a probability based upon those user interface objects which have been further identified as being configured to accept speech dictated text and those user interface objects which have been further identified as not being configured to accept speech dictated text; receiving speech input; and, biasing a determination of whether the speech input is a voice command or speech dictation based upon the computed probability.
Patent IL-173104-A0 (IL)
Title: Siva and ubiquintination
Filed: 2006-01-12
Abstract: The present invention relates to the ubiquitination and/or degradation-related activity of a SIVA polypeptide and to agents capable of modulating said activity.
Patent RO-133820-A0 (RO)
Title: Bioactive composition for healing superficial wounds
Inventor: OPRIŢA ELENA IULIA
IPC: A61K31/717
Filed: 2018-11-29
Abstract: The invention relates to a process for preparing a bioactive composition for treating superficial wounds. According to the invention, the process consists in that 80...95% mixture comprising 96...99 parts of bacterial nanocellulose of 0.4...0.6% concentration, 0.15...1.5 parts of collagen hydrolysate having an average weight of 5000...12000 Da and 1...3 parts of sorbitol or grapefruit seed extract, the parts being expressed by weight, is stirred at the room temperature for 30...60 min, further 5...20% biogenic silica solution having a silicon content of 2.3...7.5 mg/l, resulted from the fermentation of a mixture of black tea infusion, sucrose, symbiotic consortium of bacteria and yeasts, and rice hulls and/or horsetail plant powder are added, to result in a viscous solution having a dry matter content of 5...15%,which is then conditioned as a gel resorbable over time at the application site.
Patent RO-137169-A0 (RO)
Title: Sustainable concrete composition based on neutralized leachate (bsl)
Inventor: GIRLOVAN DRAGOŞ MIHAI
IPC: C04B7/24
Filed: 2022-08-09
Abstract: The invention relates to a sustainable concrete composition based on neutralized leachate (BSL). According to the invention, the concrete composition consists of cement, mineral aggregates, additives and mixing water of which a volume of up to 30% is substituted with neutralized leachate (EWC code 19 07 03), the neutralized leachate being obtained by homogenizing it with two chemical products, namely a specific composition of methylglycinediacetic acid and ferric chloride, commercially called TOx - 50, and hydrogen peroxide in a concentration of 50%, in a volume of up to 0.010% of the total volume of the neutralized leachate.
Patent RO-137517-A0 (RO)
Title: Innovative products based on passive immunization by means of anti-spike specific immunoglobulins y, intended for the prevention and treatment of sars cov2 infection and post-vaccination complications
Inventor: NICOLESCU MARIA- ANCA
IPC: C07K16/28
Filed: 2023-02-28
Abstract: The invention relates to the use of Anti S1 (Spike 1) specific IgY Immunoglobulin for the preparation of a product to be administered orally or as intranasal spray for pre- and post-exposure prophylaxis for the SARS-CoV-2 pathogen, which product comprises 40...60% anti S1 IgY, 20...25% Nattokinase, 5% Astaxanthin, 10% Glutathione, and Quercetin, respectively, 5% a combination of vitamin C/vitamin D3/Zinc and 3% Xylitol, the percentage being expressed by mass.